4-(5-(1-Aminoethyl)-6-methylpyridin-2-yl)piperazine-1-carbaldehyde

Catalog No.: 
ACPNYA150
CAS No.: 
1355226-04-8
Molecular Formula: 
C13H20N4O
Molecular Weight: 
248.33
4-(5-(1-Aminoethyl)-6-methylpyridin-2-yl)piperazine-1-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$1151.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(5-(1-Aminoethyl)-6-methylpyridin-2-yl)piperazine-1-carbaldehyde
IUPAC Name4-(5-(1-aminoethyl)-6-methylpyridin-2-yl)piperazine-1-carbaldehyde
Molecular FormulaC13H20N4O
Molecular Weight248.33
SMILESO=CN1CCN(C2=NC(C)=C(C(N)C)C=C2)CC1
InChI KeyIGZCDRMSLDXIJY-UHFFFAOYSA-N
Synonym4-[5-(1-Amino-ethyl)-6-methyl-pyridin-2-yl]-piperazine-1-carbaldehyde
CAS No.1355226-04-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPNYA150 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACPNYA150 route product structure diagram
    ACPNYA1501355226-04-8
Inquiry

2. ACPNYA150 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACPNYA150 route product structure diagram
    ACPNYA1501355226-04-8
Inquiry

3. ACPNYA150 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPNYA150 route product structure diagram
    ACPNYA1501355226-04-8
Inquiry

Comments (0)